| Top Adding |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Home Based Business > Network Marketing > Having Trouble Reaching a Specific Prospect — How to Reach That Hard-to-Reach Prospect in One Try |
|
Top Adding - Having Trouble Reaching a Specific Prospect — How to Reach That Hard-to-Reach Prospect in One Try
Wouldn’t it be easier if you were referred to your hard-to-reach prospect instead of becoming one of those dreaded cold calls? If you could get an introduction to that person from someone that you both know and trust what are your chances of getting that appointment? Pre According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product tty high, maybe on the first call…right? Law of 6 Degrees of Separation “You can reach literally anyone in the entire world through 5-6 steps.” Let's look at that concept:
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in Step 2 – 10,000 people -- If those 100 people also know 100 people, then you can reach 10,000 people just by asking everyone you know to ask for you. lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. i> here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ard this story before and networking never worked for before. Well….then you were doing it wrong! Have you been going to networking events and getting nowhere fast? No one seemed to be buying anything. A networking event is not the place to sell, it is the place to bui d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ld a network of people that beg for your help and where you help them connect through your extensive network that you continually develop. Stop seling and start networking building. The way to do that is to offer help to others to reach those they'd like to reach. Of co ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc rse you need to develop your 30-second elevator speech to the point that everyone you meet with will be compelled to ask you "how in the world do you do that" and then you'll be able to ask them who do they know who just might need that. However.....this is the MOST IMPO easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi RTANT part...you aren't tere to sell...you are there to help everyone you meet connect with THEIR MOST IMPORTANT prospect. If you do this over and over you will become the most important person in their network, and....of course they'll refer you. So, back to our origin nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically al idea, that you could find someone that knows that very important, and very hard to reach prospect. Frankly, just ask your 100 people who knows your “most important person” and then ask them to ask for you. If this 100 people trust you and believe in you, they will re and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ch 10,000 people for you. Virtual Networking Now, here’s a suggestion that will explode your reach. There are online virtual networks that let you see those principles I mentioned working in real time. Some online virtual networks are a waste of time ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi and others really work. One of those is http://www.linkedin.com I’ve been able to go on LinkedIn, type in a name, or title, or industry of someone I’ve been dying to meet and find them, or someone like them. And, si ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a nce this is a network of networkers open to the networking principle, guess what? They’ll take your call, or your request to connect. When I work this network I’ve gotten as many appointments a week as I could handle, 15-20 appointments a week with THE PEOPLE I’d like to dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod meet with. Some have been amazingly powerful and visible people that others would die to meet. Build your tier 1 LinkedIn network, and the next time you are networking face to face (at the chamber, BNI, or other networking group) you can share connections. And, even if cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin you don't have the information on the tip of your tongue when networking face to face just suggest that you are sure that you may have someone in your network and then go to LinkedIn and find that person for them. You will be a hero and they will refer you. Also, Linked tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen In allows you to send an invitation to the network. Right after a live networking event invite everyone you meet with to LinkedIn and show them how big of a network you have built. Once someone is on your LinkedInd virtual network you can see all of the people they have, t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel or will have in their network. Networking with the RIGHT People One key concept is to network with the right people. If your networking with people who couldn’t possibly know directly the people you’d like to reach, yes you would eventually be able to ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust reach them through several steps of your networking, but by raising your tier 1 and tier 2 levels to the economic level, or power socializing level of your targets you’ll be reaching your target in 1-2 steps. I once asked a contact if he knew someone who would be intere y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products sted in helping one of my clients develop an Asian distribution system. He seemed to be someone who should know someone that does that, but I didn’t expect him to be the one. His response was that he was a partner with the ex-ambassador to China and they both own a large . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de Asian distribution company. The stories go on and on like this. Simple Steps So, here’s the bottom line on how to reach your hard-to-reach prospect:
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip network (virtual or live)…and keep asking. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Apple Inc - A Case Study In Innovation - Part 1 Innovation Management - Raw brainpower versus experience Health Insurance Plans Compared
|